Role of innate immunological/inflammatory pathways in myelodysplastic syndromes and AML: a narrative review
|
Jul 2023
|
Experimental Hematology & Oncology
|
myelodysplastic syndromes (MDS)
|
Role of Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem-Cell Transplantation in Older Patients With De Novo Myelodysplastic Syndromes: An International Collaborative Decision Analysis.
|
Jun 2013
|
J Clin Oncol
|
myelodysplastic syndromes (MDS)
|
Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy
|
Jun 2017
|
Br J Haematol
|
myelodysplastic syndromes (MDS)
|
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
|
Jan 2024
|
Lancet Hematology
|
myelodysplastic syndromes (MDS)
|
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial
|
Aug 2020
|
Lancet Hematology
|
acute myeloid leukemia (AML), myelodysplastic syndromes (MDS)
|
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes
|
Jan 2017
|
Ther Adv Hematol
|
myelodysplastic syndromes (MDS)
|
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes
|
Jun 2016
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
Searching for a Light at the End of the Tunnel? Beyond Hypomethylating Agents in Myelodysplastic Syndromes.
|
Jan 2017
|
Am Soc Clin Oncol Educ Book
|
myelodysplastic syndromes (MDS)
|
Second allogeneic hematopoietic stem cell transplantation in children with severe aplastic anemia
|
Jun 2015
|
Bone Marrow Transplant
|
aplastic anemia
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
Jul 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|